Literature DB >> 27365755

Correlation of CD4+ T cell Count with Total Lymphocyte Count, Haemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-1 Disease.

Sourav Sen1, Akshat Vyas2, Sunil Sanghi3, K Shanmuganandan4, R M Gupta5, Brig Ketoki Kapila6, A K Praharaj7, Satish Kumar1, R B Batra8.   

Abstract

BACKGROUND: Studies in human immunodeficiency virus (HIV) infected adults have demonstrated association of total lymphocyte count (TLC) <1200/mm (3) and subsequent disease progression or mortality. The association of other surrogate makers such as haemoglobin (Hb), and erythrocyte sedimentation rate (ESR) with CD4 count and disease progression has also been suggested. This study was carried out to determine the relationship of CD4-positive T lymphocyte counts with TLC, Hb and ESR in HIV-infected individuals.
METHODS: The study population comprised of 215 antiretroviral treatment naïve HIV-1 infected adults. The CD4 positive T cell counts, TLC, Hb and ESR of study participants were measured. Spearman's rank order correlation and Receiver Operating Characteristic were used for statistical analyses. RESULT: The sensitivity, specificity, positive and negative likelihood ratios for cut-off value of TLC <1200/mm (3) for predicting CD4 counts <200 cells/mm (3) and <350 cells/mm (3) were 9.4 %, 100 %, not measurable and 1.1, and 6.1 %, 98.8 %, 5.13 and 0.95, respectively. The association of Hb (<10,11,12 g/dl and <10,12,14 g/dl for CD4 counts <200 cells/mm (3) and <350 cells/mm (3) , respectively), and ESR (<10, 20 and 30 mm fall after 1 hour) with these two CD4 counts cut-off values were suboptimal.
CONCLUSION: This study reveals the poor association of TLC, Hb, and ESR with CD4 counts in HIV infected adults, thus highlighting the need to review the utility of these surrogate markers, for predicting CD4 counts in people living with HIV/AIDS.

Entities:  

Keywords:  Erythrocyte sedimentation rate; Haemoglobin; Human immunodeficiency virus; Total lymphocyte count

Year:  2011        PMID: 27365755      PMCID: PMC4920621          DOI: 10.1016/S0377-1237(11)80005-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  15 in total

1.  Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.

Authors:  Anish P Mahajan; Joseph W Hogan; Brad Snyder; N Kumarasamy; Kalindi Mehta; Suniti Solomon; Charles C J Carpenter; Kenneth H Mayer; Timothy P Flanigan
Journal:  J Acquir Immune Defic Syndr       Date:  2004-05-01       Impact factor: 3.731

2.  [Relation between erythrocyte sedimentation rate, clinical and immune status and virus load in non-hospitalized HIV-infected patients].

Authors:  E G Vázquez; M de Górgolas; M L Guerrero
Journal:  Rev Esp Quimioter       Date:  2001-09       Impact factor: 1.553

3.  Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection.

Authors:  Bryan Lau; Stephen J Gange; John P Phair; Sharon A Riddler; Roger Detels; Joseph B Margolick
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-15       Impact factor: 3.731

4.  Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.

Authors:  Lisa A Spacek; Michael Griswold; Thomas C Quinn; Richard D Moore
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

5.  Use of surrogate markers to predict the HIV disease stage and time to initiate antiretroviral therapy in developing countries.

Authors:  Monica Chaudhary; Bineeta Kashyap; Hitender Gautam; Sanjeev Saini; Preena Bhalla
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2008-09-09

6.  Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients.

Authors:  M A Ndakotsu; L Salawu; M A Durosinmi
Journal:  Niger J Med       Date:  2008 Oct-Dec

7.  Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.

Authors:  B Gitura; M D Joshi; G N Lule; O Anzala
Journal:  East Afr Med J       Date:  2007-10

8.  Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population.

Authors:  Susan C Morpeth; John A Crump; Humphrey J Shao; Habib O Ramadhani; Peter R Kisenge; Cindy A Moylan; Susanna Naggie; L Brett Caram; Keren Z Landman; Noel E Sam; Dafrosa K Itemba; John F Shao; John A Bartlett; Nathan M Thielman
Journal:  AIDS Res Hum Retroviruses       Date:  2007-10       Impact factor: 2.205

9.  Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.

Authors:  Amita Gupta; Nikhil Gupte; Ramesh Bhosale; Arjun Kakrani; Vandana Kulkarni; Uma Nayak; Madhuri Thakar; Jayagowri Sastry; Robert C Bollinger
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731

10.  Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index.

Authors:  David M Moore; Anna Awor; Robert S Downing; Willy Were; Peter Solberg; David Tu; Keith Chan; Robert S Hogg; Jonathan Mermin
Journal:  AIDS Res Ther       Date:  2007-01-18       Impact factor: 2.250

View more
  6 in total

1.  CD4 Cell Counts, Lipid Profile, and Oral Manifestations in HIV-Infected and AIDS Patients.

Authors:  Koduri Sridevi; Saka Malathi; Chalapathi Kv; Chowdary Nagarjuna G; M Gayathri; G Eswar Chand; Abhishek Singh Nayyar
Journal:  Front Dent       Date:  2019-12-20

2.  CD4 cell counts and oral manifestations in HIV infected and AIDS patients.

Authors:  Mvr Ratnam; Abhishek Singh Nayyar; D Santhosh Reddy; B Ruparani; K V Chalapathi; Sania Md Azmi
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

3.  Clinical spectrum of renal disease in hospitalized HIV/AIDS patients: A teaching hospital experience.

Authors:  Bhupendra Verma; Amrita Singh
Journal:  J Family Med Prim Care       Date:  2019-03

4.  Covariate random effects on the CD4 count variation during HIV disease progression in women.

Authors:  Partson Tinarwo; Temesgen Zewotir; Delia North
Journal:  HIV AIDS (Auckl)       Date:  2019-05-20

5.  An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa.

Authors:  Partson Tinarwo; Temesgen Zewotir; Nonhlanhla Yende-Zuma; Nigel J Garrett; Delia North
Journal:  Infect Dis Ther       Date:  2019-02-12

6.  Evaluation of Individual and Combined Markers of Urine Dipstick Parameters and Total Lymphocyte Count as a Substitute for CD4 Count in Low-Resource Communities in Ghana.

Authors:  Enoch Odame Anto; Christian Obirikorang; Emmanuel Acheampong; Bright Amankwaa; Bright Oppong Afranie; Sampson Donkor; Isaac Hope; Juliana Jommo; Esther Osaah
Journal:  Dis Markers       Date:  2018-02-11       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.